hTID1, a human homologue of Drosophila tumor suppressor, I(2)tid regulates the release of cytochrome c from mitochondria and subsequent alteration of caspase-3 activity on apoptosis induced by exogenous stimuli, such as tumor necrosis factor-a and mitomycin C. To search for an interacting molecule with hTid1, we applied twohybrid yeast screening and isolated a novel gene, which encodes a 46 kDa protein of 373 residues. Within the deduced amino acid sequence, a region showing homology to the Ring Finger domain of X-linked inhibitor of apoptosis protein was identified and the gene was designated as hRFI, standing for human Ring Finger homologous to IAP type. A 2.0 kb hRFI transcript was ubiquitously expressed in all human tissues as well as several cancer cell lines examined. Northern blot analysis showed that in 70% (14 out of 20) of esophageal cancer patients, expression of hRFI in cancerous regions was two or more times higher than in the corresponding normal tissues. HeLa cells transfected with hRFI construct exhibited a tendency to resist TNF-a induced apoptosis, suggesting an anti-apoptotic function of the hRFI product. Finally, hRFI protein was shown to be cleaved within the DEDD sequence spanning residues 230 -233 by caspase-3 during the apoptotic induction.
Introduction
The Drosophila tumor suppressor lethal(2) tumorous imaginal discs, l(2)tid, encodes a protein which is located in the mitochondria (Syken et al., 1999) and plays a role in differentiation of the imaginal disc, presumably by eliminating mis-directed progenitors. This notion arose from evidence that null mutants of Tid exhibit a lethal phenotype in which cells of the imaginal discs fail to differentiate and grow into a lethal tumor (Syken et al., 1999) . A human homolog of l(2)tid, TID-1, has been cloned during two-hybrid yeast screening in an attempt to find a protein interacting against the E7 oncoprotein of human papilloma virus 16 (Schilling et al., 1998) , and its genomic organization and expression has been reported (Yin et al., 2001) .
Drosophila l(2)tid and human TID-1 encode 56 kDa and 45.6 kDa proteins, respectively (Syken et al., 1999) . Both products are post-translationally cleaved at their mitochondrial processing sites located close to their Ntermini, and the cleaved molecules are moved into the mitochondria. Through the alternative splicing mechanism, hTID-1 is transcribed into the two variant forms termed hTid-1L and hTid-1S. The use of an exon located in the 3' untranslated region in the context of hTID-1L transcript generates the shorter form in which the C terminal 33 residues of the L form are replaced with six residues, unique to the S form. On apoptosis induction with mitomycin C (MMC) or tumor necrosis factor-a (TNF-a) treatment, both hTID-1L and -1S affect the cell apoptosis in opposite ways by regulating the release of cytochrome c from mitochondria and subsequent alteration of caspase-3 activity, although they do not elicit any detectable apoptosis by themselves (Syken et al., 1999) . hTID-1 transfectant, when treated with MMC or TNF-a, exhibits an augmented release of cytochrome c and increased caspase-3 activity as compared with those observed in parental non-transfectant, whereas hTID-1S transfectant shows an inhibitory effect. Thus the L form acts to promote and the S form acts to suppress cell apoptosis. These observations clearly indicate that hTID-1 plays an important role in the apoptotic pathway which presumably regulates the expansion of tumor cell progenitors.
By applying two-hybrid yeast screening using hTID-1 as a bait, we isolated a novel gene which is preferentially expressed in esophageal cancer cells.
Results
In the two-hybrid yeast screening of 3.4610 7 colony forming units (cfu), using hTID-1 as a bait, we isolated 106 positive clones. Subsequent computer search analysis showed that one of the clones encodes a Ring Finger motif, similar to that of the X-chromosomelinked inhibitor of apoptosis protein (XIAP). Twentytwo residues within this motif are identical to the Ring Finger domain spanning 53 residues of XIAP. XIAP is a member of the inhibitor of apoptosis protein (IAP) family of genes and most of them share the Ring Finger domains on their C termini. Instead of its strong homology to the XIAP Ring Finger domain, the rest of the sequence is different from that of XIAP. Another domain which is totally conserved in members of the entire IAP family is the baculoviral inhibition of apoptosis protein repeat (BIR) domain (Birnbaum et al., 1994) . This domain is indispensable for their antiapoptotic function (Takahashi et al., 1998) . Since the deduced amino acid sequence of the present isolate lacks this domain, it is not permissible to classify this gene in the IAP family. We therefore designated it as Ring Finger homologous to IAP type, RFI. The nucleotide and predicted amino acid sequences of RFI cDNA are shown in Figure 1 . The predicted molecular weight of RFI products, Rfi was estimated to be approximately 46 kDa. Within Rfi, an acidic region composed of aspartic and glutamic acid stretches which shows homology to the Daxx protein (Yang et al., 1997) was also identified.
The genomic organization of the hRFI gene was studied by isolating a bacterial artificial chromosome (BAC) clone spanning the RFI genomic locus. This clone, 339f24, was first used to determine the exonintron boundaries of RFI. The RFI gene is composed of 6 exons, transcribed into two variant forms derived from the presence of two distinct first exons (Figure 2 ) (Kozak, 1983) . Sequences flanking exon -intron boundaries matched with the GT-AG rules (Table 1) . Multiple tissue Northern blot analysis showed that the RFI gene was ubiquitously expressed in various kinds of human tissue as well as several cancer cell lines. Of these, a higher level of expression was observed as a 2.0 kb transcript in the testis, ovary, heart and skeletal muscles (Figure 3 ). The BAC clone 339f24 was further used as a probe on normal metaphase peripheral blood lymphocytes for fluorescence in situ hybridization (FISH) analysis combined with reverse 4'6'-diamidino-2-phenylindole (DAPI) staining. This analysis localized the hRFI gene on chromosome 12q23-24.1 where the loss of heterozygosity (LOH) is frequently observed in several cancers including those of ovary and esophagus (Hatta et al., 1997; Pack et al., 1999) . Based on the chromosomal location of the RFI gene, we examined its expression in esophageal cancer cells. A Northern blot containing 20 pairs of esophageal cancer specimens and surrounding normal tissues was probed with hRFI cDNA. In each case, the intensity of RFI transcripts detected (in cancerous and normal tissues) was converted to a digital value and the values of cancerous versus normal tissues were calculated as a tumor/normal ratio. As shown in Figure 4 , more than twice the expression of RFI in cancerous tissue was scored in 14 cases.
To characterize hRFI protein, Rfi, we generated a rabbit antibody against the entire region and used this for Western blot detection and for staining cells. Nuclear and cytoplasmic fractions were prepared from Jurkat cells and their integrity was first examined on a Western blot by probing with anti-TFIID antibody for the nuclear fraction and with anti-b-actin antibody for the cytoplasmic fraction. This analysis showed that the most of the TFIID and b-actin was detected in the nuclear and cytoplasmic preparations, respectively. Probing the same blot with anti-RFI antibody revealed the presence of hRfi both in nuclear and cytoplasmic fractions ( Figure 5a ). Staining of the HeLa cells transfected with hRFI construct further confirmed the dual location of hRFI. As shown in Figure 5b , hRfi is stained as speckles in the cell nuclei, but homogenously in the cytoplasm. It is noteworthy that the homogenous staining pattern of Rfi in the cytoplasm is completely different from that of hTid-1 which is localized in the mitochondria.
To further explore the function of Rfi, HeLa cells were co-transfected with hRFI and lacZ constructs, and the transfected cells were treated with a combination of TNF-a and cycloheximide (CHX). As compared with the surviving cell rate scored in transfection with lacZ construct alone, the co-transfectant displays a higher score at each time point after the apoptotic induction. The %-difference of surviving cell rate between hRFI expressing and control cell was shown in Figure 6 . This result indicates that hRfi may exert an antiapoptotic effect on TNF-a induced cell death.
During the TNF-a induced apoptosis of HeLa cells, we noticed that the hRfi renders its molecular weight from 46 kDa to 22 kDa. The proportion of small size hRfi was estimated about 7.6% by densitometry. This observation was mostly remarkable 4 h after the induction, and was parallel with the time course of caspase-3 activity, suggesting a caspase-3 mediated cleavage of hRfi (Figure 7 ). To examine this possibility, wild-type hRfi produced by the in vitro transcription/ translation system was incubated with caspase-2, Figure 3 Multi-tissue Northern blot analysis Figure 4 The result of Northern blot analysis in 20 pairs of esophageal carcinomas and corresponding normal tissues. In 70% of cases, expressions of hRFI in carcinomas were two or more times higher than those in normal tissues
Preferential expression of hRFI in esophageal cancer S Sasaki et al caspase-3 or caspase-8. As shown in Figure 8 , hRfi was specifically cleaved by caspase-3 and submolecules of 35 kDa and 22 kDa were generated, while no cleavage was detected in Bcl2 protein. The consensus sequence of the caspase-3 cleavage site is DEXD, in which X indicates any amino acid. Close inspection of the caspase-3 cleavage site within the hRfi sequence showed the presense of two potential cleavage sites including DEDD at residues 230 -233 and DEED at residues 319 -322. To localize the cleavage sites, two submolecules, each spanning a single potential cleavage site, were generated. As shown in Figure 8 , the polypeptide spanning DEDD (230 -233) was cleaved while the other spanning DEED (319 -322) was not. This analysis clearly showed that DEDD at residues 230 -233 of Rfi is catalyzed by caspase-3.
Discussion
We isolated a novel gene, RFI, which was initially identified as a positive clone in a two-hybrid yeast screening using a human homolog of Drosophila tumor suppressor l(2)tid. The most critical issue concerning RFI is whether its product physically interacts with hTid. Neither GST pull-down in vitro binding assay nor in vivo binding assay applying an immunoprecipitation procedure with co-transfectant expressing Rfi and Tid elicited any proof of physical association between these molecules (data not shown). These results may be interpreted as due to an instability of the Tid precursor molecule which is known to be cleaved near its N-terminal and enter into mitochondria. Our staining study localized Rfi as diffusely distributed in cytoplasm which is completely different from the staining pattern of hTid localized in mitochondria, although we cannot exclude that a minute amount of Rfi may be localized in mitochondria. Presumably, the Rfi interaction would direct against the precursor form of hTid. In the present study, hRFI was mapped on human chromosome 12q23-24.1, where frequent LOH has been reported in several cancers including those of ovary and esophagus (Hatta et al., 1997; Pack et al., 1999) . By applying comparative genomic hybridization (CGH), Pack et al. reported that the frequencies of LOH and chromosomal gain in 12q in esophageal cancers were 70 and 59%, respectively (Pack et al., 1999) . In addition, Merup et al. found amplification of the region 12q23-24 in chronic lymphocytic leukemia (CLL) (Merup et al., 1997) . These observations prompted us to examine a possible involvement of the hRFI gene in these malignancies. In the present study including 50 cases with CLL, no rearrangement, mutation or altered expression level of the RFI gene was detected (data not shown). In contrast to CLL, we found more than twofold increased expression of the RFI gene in 70% of cases with esophageal cancer, as estimated by a comparison with the expression in surrounding normal tissue. Because the number of patients with esophageal cancers examined was small, further examination should be needed. No mutation in The designation of RFI is based on its homology with the XIAP Ring Finger domain. IAP was originally discovered in the baculovirus genome whose protein product confers an anti-apoptotic effect to its host cells (Clem et al., 1991; Crook et al., 1993) . Currently, six members of the IAP family, including c-IAP1, c-IAP2, XIAP, NIAP, survivin, and Apollon have been isolated in human (Hay et al., 1995; Roy et al., 1995; Rothe et al., 1995; Duckett et al., 1996; Liston et al., 1996; Uren et al., 1996; Ambrosini et al., 1997; Chen et al., 1999) . The BIR domain, initially recognized in the IAP molecule derived from the baculovirus genome and composed of approximately 70 amino acids (Birnbaum et al., 1994) , is well conserved in all six molecules. The mode of apoptotic inhibition exhibited by the IAPs is closely associated with the apoptotic pathway mediated by the caspase, and the presence of the BIR domain is essential for this inhibition (Takahashi et al., 1998; Deveraux et al., 1997 Deveraux et al., , 1998 Roy et al., 1997) . Another domain relatively well conserved in the IAP family proteins is the C-terminus Ring Finger. Although the function of Ring Finger is not yet known, this domain is not required for the inhibition of caspase activity (Takahashi et al., 1998) and is probably involved in protein-protein interaction. In addition, Yang et al. reported that the Ring Finger domains of cIAPs and XIAP have E3 (ubiquitin protein ligase) activities, which lead to auto-ubiquitination, degradation, and progression towards cell death (Yang et al., 2000) .
Until now, many of the proteins particularly involved in the apoptotic process have been identified as substrates of caspase (Wolf et al., 1999) . Caspase mediated cleavage in these proteins frequently contributes to the promotion of apoptosis. The significance of caspase-3 mediated cleavage of Rfi in the apoptotic process is still not known. We found that the emerging anti-apoptotic effect of Rfi precedes the generation of the cleavage product. Therefore it seems unlikely that caspase-3 mediated Rfi cleavage contribute to its anti-apoptotic activity.
Materials and methods

Two-hybrid yeast system
The full-length cDNA of hTID-1L gene was subcloned into the pLexA vector (Clontech) such that the protein would be generated as in-frame fusions with the LexA DNA-binding domain. An oligo(dT)-primed cDNA library was prepared from mRNA isolated from the human prostate cancer cell line DU145, and subcloned into the pB42AD vector. These two plasmids were cotransfected into EGY48(p8op-lacZ). Screening and verification of the specificity of the interactions were performed according to manufacturer's instructions. For positive clones, their inserts were polymerase chain reaction (PCR) amplified, sequenced and analysed by using BLAST program. Full length hRFI cDNA was isolated from a nonamplified human testis cDNA library of 1610 6 clones probing with a partial hRFI cDNA clone initially isolated from the two-hybrid yeast screening.
Northern blot analysis
Multiple tissue mRNA blots (Clontech) were purchased and hybridized according to the manufacturer's protocols. A 191-bp PCR product of hRFI, generated with a pair of primers 1F (GATGACGACGATGATGAGG: 676-694 nt) and 4R (TCACAACAGCCAGAATAGTTG: 846-866 nt), was used as a probe. We also prepared Northern blots of mRNA isolated from 20 pairs of esophageal carcinomas and corresponding normal tissues, which were surgically resected at Medical Institute of Bioregulation, Kyushu University (Japan) and performed the same procedure as above. b-actin was used as a control. Signal intensity was quantified by using Personal Densitometer SI (Molecular Dynamics) and in each case the digital value was calculated by following formula: the tumor/normal ratio=(C RFI 6N b-actin )/(C b-actin 6 N RFI ). C and N indicate signal intensity for cancerous and normal tissue, respectively.
Screening of BAC library
Using primers 1F and 4R which were able to amplify a 433-bp product on human genomic DNA, we performed PCR screening for a human genomic BAC library (Research Genetics) according to the manufacturer's protocols. One BAC clone (339f24) spanning the entire locus of hRFI gene was identified and used as template for the following sequencing and FISH analysis.
Generation of anti-hRFI antibody
Full-length cDNA of hRFI was inserted into pET23d (Novagen) and expressed in Escherichia coli. The polypeptide was purified by applying to a Ni-NTA resin (Qiagen) and used to immunize rabbits. Rabbit antiserum was purified by applying to the polypeptide column.
Immunofluorescence staining for cellular localization of hRFI gene products Full-length hRFI was subcloned into pcDNA3.1/V5-His vector (Invitrogen). Hela cells were cultured in DMEM supplemented with 10% FBS and penicillin (100 units/ml)-streptomycin (100 mg/ml). Twenty-four hours after seeding, HeLa cells were transfected with pcDNA3.1/V5-His/RFI by GenePorter 2 transfection reagent (Gene Therapy Systems), according to the manufacturer's protocols. Two days after transfection, cells were rinsed with TBS/CaCl 2 (10 mM Tris, 150 mM NaCl, 2 mM CaCl 2 , pH 7.4) for three times, and fixed in acetone/methanol 1 : 1 for 30 s. The fixed cells were incubated with anti-hRFI antibody at a concentration of 20 mg/ml for 1 h at room temperature, followed by an incubation with anti-rabbit IgG-FITC (SantaCruz). Intra cellular localization of RFI protein was examined under fluorescence microscopy.
Cellular fractionation
Jurkat cells were maintained in RPMI 1640 medium supplemented with 10% FBS and penicillin (100 units/ml)-streptomycin (100 mg/ml). Nuclear and cytoplasmic extracts were prepared separately by NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce) according to the manufacturer's protocols. Both extracts were separated by a SDS -PAGE, blotted and detected sequentially with anti-TFIID antibody (SantaCruz), anti-b-actin antibody (Sigma) and anti-hRFI antibody. Each after the detection, the membrane was treated at 558C for 30 min in the solution containing 62.5 mM Tris, pH 7.4, 2% SDS, and 0.7% bmercaptoethanol to strip-off antibodies.
Induction of apoptosis with TNF-a
Hela cells were plated in 10 cm culture dishes (2610 6 cells). Twenty-four hours after plating, 10 ng/ml of TNF-a and 1 mg/ml of CHX were added. Cells were harvested at 0, 2, 4, and 8 h after the treatment and lyzed in the lysis buffer: Phosphate buffered saline containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM PMSF, 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin. 40 mg aliquots of whole cell lysates were separated on 12.5% SDS-polyacryl amide gel electrophoresis (SDS -PAGE), blotted and probed with anti-hRFI antibody at a concentration of 1 mg/ml. The same preparation was also assayed quantitatively for caspase-3 by Caspase-3/CPP32 Colorimetric Assay Kit (BioVision) according to the manufacturer's protocols.
In vitro cleavage study of RFI protein Two subfragments of hRFI cDNA as shown in Figure 8 , panel C, were amplified by PCR procedure and subcloned into pET23a (Novagen) or pcDNA3.1/His (Invitrogen) vector. Bcl2 was also subcloned into pcDNA3.1/His vector as a control. These recombinants were used as templates to generate 35 Slabeled polypeptides by using TNT Coupled Reticulocyte Lysate System (Promega). Recombinant human caspase-2 was from R & D System, caspase-3 from Pharmingen and caspase-8 from Sigma. 1*2 ml aliquot of the translation product was incubated with each caspase under optimal conditions according to the manufacturer's recommendation, and the reaction product was resolved on 15% SDS -PAGE, followed by a detection with autoradiography.
Transfection and counting of surviving cells during apoptosis
Hela cells were plated to 6-well dishes so that their confluency would be 60 -80% on next day. pcDNA3.1/His/lacZ alone or mixed with pcDNA3.1/V5-His/RFI were transfected by GenePORTER 2 (Gene Therapy System). Forty-eight hours after transfection, apoptosis was induced by addition of 10 ng/ml of TNF-a and 1 mg/ml of CHX. 1, 2, and 4 h later, cells were stained with X-Gal using b-gal Staining Kit (Invitrogen) and surviving cells among 200 stained cells were counted morphologically.
